Browse by outcome
Choose an intervention dossier to evaluate the supplied synthesis and supporting evidence.
This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.
23 of 23 dossiers shown
Insulin therapy → Glucose iAUC (OGTT)
Insulin therapy shows a moderate positive evidence signal for improving Glucose iAUC (OGTT) across the studied comparisons.
Empagliflozin → Fasting Plasma Glucose (FPG)
Empagliflozin shows a moderate positive evidence signal for improving Fasting Plasma Glucose (FPG) across the studied comparisons.
Structured multidisciplinary case management → Fasting Plasma Glucose (FPG)
Structured multidisciplinary case management shows a strong positive evidence signal for improving Fasting Plasma Glucose (FPG) across the studied comparisons.
Continuous glucose monitoring → Time above range
Continuous glucose monitoring does not show benefit for Time above range in the available evidence and may be associated with worse results.
Insulin therapy → Blood glucose
Insulin therapy has a small positive evidence signal for Blood glucose, but the clinical interpretation is limited.
Continuous glucose monitoring → Time below range
Continuous glucose monitoring has a small positive evidence signal for Time below range, but the clinical interpretation is limited.
Dipeptidyl peptidase-4 inhibitors → Fasting Plasma Glucose (FPG)
Dipeptidyl peptidase-4 inhibitors shows a moderate positive evidence signal for improving Fasting Plasma Glucose (FPG) across the studied comparisons.
Metformin → Fasting blood sugar (FBS)
Metformin shows a moderate positive evidence signal for improving Fasting blood sugar (FBS) across the studied comparisons.
Hybrid closed-loop system → Glucose variability
Hybrid closed-loop system has a small positive evidence signal for Glucose variability, but the clinical interpretation is limited.
Dapagliflozin → Fasting Plasma Glucose (FPG)
Dapagliflozin shows a moderate positive evidence signal for improving Fasting Plasma Glucose (FPG) across the studied comparisons.
Lifestyle intervention for prediabetes → Fasting blood sugar (FBS)
Lifestyle intervention for prediabetes has a small positive evidence signal for Fasting blood sugar (FBS), but the clinical interpretation is limited.
Usual care → Fasting Plasma Glucose (FPG)
Usual care has not shown a clear effect on Fasting Plasma Glucose (FPG) in the available evidence.
Resistance training → 2-hour plasma glucose
Resistance training has not shown a clear effect on 2-hour plasma glucose in the available evidence.
Hybrid closed-loop system → Time above range
Hybrid closed-loop system shows a moderate positive evidence signal for improving Time above range across the studied comparisons.
Vitamin D supplementation → Blood glucose
Vitamin D supplementation has a small positive evidence signal for Blood glucose, but the clinical interpretation is limited.
Continuous glucose monitoring → Time in range
Continuous glucose monitoring shows a moderate positive evidence signal for improving Time in range across the studied comparisons.
Metformin → Glucose iAUC (OGTT)
Metformin shows a moderate positive evidence signal for improving Glucose iAUC (OGTT) across the studied comparisons.
Insulin therapy → Time in range
Insulin therapy has a small positive evidence signal for Time in range, but the clinical interpretation is limited.
Metformin → Fasting Plasma Glucose (FPG)
Metformin shows a moderate positive evidence signal for improving Fasting Plasma Glucose (FPG) across the studied comparisons.
Lifestyle intervention for prediabetes → 2-hour plasma glucose
Lifestyle intervention for prediabetes has a small positive evidence signal for 2-hour plasma glucose, but the clinical interpretation is limited.
Vitamin D supplementation → Fasting Plasma Glucose (FPG)
Vitamin D supplementation has not shown a clear effect on Fasting Plasma Glucose (FPG) in the available evidence.
Hybrid closed-loop system → Time in range
Hybrid closed-loop system shows a moderate positive evidence signal for improving Time in range across the studied comparisons.
Multi-species synbiotic (12 probiotic strains + FOS prebiotic) → Fasting Plasma Glucose (FPG)
Multi-species synbiotic (12 probiotic strains + FOS prebiotic) shows a strong positive evidence signal for improving Fasting Plasma Glucose (FPG) across the studied comparisons.
